Geir Christian Melen

Geir Christian Melen has a long history of work experience, starting as a Finance Manager at Saga Petroleum AS in 1990. Geir Christian then moved on to become CFO of Photocure ASA in 1997, followed by CFO of Algeta ASA in 2005, CEO of Clavis Pharma ASA in 2008, CEO of Ostomycure AS in 2010, CFO of Tellus Petroleum AS in 2012, and Management Consultant at Oncoinvent AS in 2018. Geir Christian currently holds the position of Finance Director at Zelluna Immunotherapy, a cell therapy company dedicated to the development of innovative immunotherapies for the treatment of a broad range of cancers with a high unmet medical need.

Geir Christian Melen attended the Norwegian School of Economics (NHH) from 1985 to 1989, where they earned an M.Sc in Business and Administration (Siviløkonom).